Literature DB >> 32297180

Predictors of symptom burden among hemodialysis patients: a cross-sectional study at 13 hospitals.

Reema Karasneh1, Sayer Al-Azzam2, Shoroq M Altawalbeh2, Osama Y Alshogran2, Sahar Hawamdeh2.   

Abstract

PURPOSE: This study investigated the clinical characteristics and symptomatology of ESRD patients in Jordan taking a multidimensional approach.
METHODS: This was a cross-sectional study that included a cohort of 620 patients undergoing maintenance hemodialysis (HD). Data were retrieved via patient survey administration and electronic health records. A modified version of the Charlson Comorbidity index (CCI) was utilized to assess comorbidity. Symptoms were assessed using the validated Arabic version of the CKD Symptom Burden Index (CKD-SBI).
RESULTS: The mean (± SD) age of participants was 50.9 ± 16.1 years, with the 59.8% being males. Diabetes was the leading cause of kidney disease among patients (29.2%), followed by hypertension (20.7%) and medication use (8.6%). Common comorbidities included hypertension (72.4%), diabetes (38.4%), and cardiovascular disease (18.7%). Patients experienced 13 CKD-related symptoms on average, with a total symptom burden score of 29.6. Muscle strain was the most common symptom (62.6%), followed by itchiness (59.7%), nervousness (57.7%), and anxiety (57.7%). Charlson comorbidity index (CCI) [β = 0.88, 95% CI (0.34-1.41)], male gender [β = - 5.59; 95% CI (- 8.34 to - 2.85)], higher educational level [β = - 3.38; 95% CI (- 6.39 to - 0.37)], and number of dialysis sessions/week (β = 6.22, 95% CI 3.37-9.07) were independent predictors of total symptom burden. Similarly, these factors predicted symptom troublesomeness, intensity, and recurrence.
CONCLUSION: A holistic clinical picture of ESRD that includes multidimensional symptom assessment is warranted for better disease management and resource allocation. Our paper identifies key characteristic of this population and factors contributing to total symptom burden.

Entities:  

Keywords:  ESRD; Kidney disease; Predictors; Symptom burden

Mesh:

Year:  2020        PMID: 32297180     DOI: 10.1007/s11255-020-02458-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  The role of clinical pharmacist in enhancing hemodialysis patients' adherence and clinical outcomes: a randomized-controlled study.

Authors:  Osama Y Alshogran; Manar H Hajjar; Suhaib M Muflih; Karem H Alzoubi
Journal:  Int J Clin Pharm       Date:  2022-07-12

2.  Factors Associated with Symptom Burden in Adults with Chronic Kidney Disease Undergoing Hemodialysis: A Prospective Study.

Authors:  Thalwaththe Gedara Nadeeka Shayamalie Gunarathne; Li Yoong Tang; Soo Kun Lim; Nishantha Nanayakkara; Hewaratne Dassanayakege Wimala Thushari Damayanthi; Khatijah L Abdullah
Journal:  Int J Environ Res Public Health       Date:  2022-05-03       Impact factor: 4.614

3.  Impact of COVID-19 Pandemic on Elevated Anxiety Symptoms of Maintenance Hemodialysis Patients in China: A One-Year Follow-Up Study.

Authors:  Honghong Lv; Junping Meng; Yang Chen; Feng Yang; Wen Wang; Guohua Wei; Jiaojiao Zhang; Huan Wang; Mengqiu Wang; Lu Zhou; Hongbao Liu
Journal:  Front Psychiatry       Date:  2022-05-19       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.